Status:

UNKNOWN

Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease

Lead Sponsor:

Sheba Medical Center

Collaborating Sponsors:

Brainsway

ElMindA Ltd

Conditions:

Parkinson

Eligibility:

All Genders

40-75 years

Phase:

NA

Brief Summary

* To characterize physiological biomarkers of positive response to rDTMS using EEG and functional MRI (fMRI) in patients with PD. * To develop a set-up and algorithm for neurophysiological monitoring ...

Detailed Description

PD Patients aged 40 years or older, diagnosed as idiopathic PD according to the UK Brain Bank criteria will be treated by an established rDTMS protocol will be monitored before, during and after rDTMS...

Eligibility Criteria

Inclusion

  • Idiopathic PD patients aged 40-75 years;
  • Hoehn and Yahr stages II to IV
  • Patients on stable antiparkinsonian therapy for 1 month
  • Right hand dominance with right afflicted side.

Exclusion

  • Participation in current clinical study or clinical study within 30 days prior to this study.
  • Subject has an atypical parkinsonian syndrome or secondary parkinsonism (e.g., due to drugs, metabolic neurogenetic disorders, encephalitis, cerebrovascular disease or other degenerative disease)
  • Patients with significant psychiatric symptoms or history.
  • Patients with psychotic symptoms or active depressive symptoms
  • Treatment with neuroleptics.
  • Beck depression inventory (BDI) score \<14
  • Mini Mental status examination (MMSE) score \<25
  • History of migraine or frequent or severe headaches.
  • Significant sensory deficits, e.g., deafness or blindness History of head injury or neurosurgical interventions.
  • Subjects who have concomitant epilepsy, a history of seizure/s, heat convulsions or history of epilepsy in first degree relative.
  • History of any metal in the head (outside the mouth).
  • The presence of cochlear implants
  • Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps.
  • Subjects with an unstable medical disorder.
  • Current drug abuse (including Cannabis) or alcoholism.
  • Pregnancy or not using a reliable method of birth control.
  • Patients with severe tremor or dyskinesia

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT02249715

Start Date

November 1 2014

Last Update

September 26 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.